Jeung Hei-Cheul, Che Xiao-Fang, Haraguchi Misako, Furukawa Tatsuhiko, Zheng Chun-Lei, Sumizawa Tomoyuki, Rha Sun-Young, Roh Jae Kyung, Akiyama Shin-ichi
Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1, Sakuragaoka, Kagoshima, 890-8520, Japan.
Biochem Pharmacol. 2005 Jul 1;70(1):13-21. doi: 10.1016/j.bcp.2005.04.017.
We investigated the ability of thymidine phosphorylase (TP) to confer cancer cells resistance to MIA (microtubule-interfering agents)-induced apoptosis. Jurkat cells were stably transfected with TP cDNA (Jurkat/TP) and the sensitivity to MIAs were examined. Jurkat/TP cells were more resistant to apoptosis induced by nocodazole, vincristine, vinblastine, paclitaxel and 2-methoxyestradiol than mock-transfected Jurkat/CV cells. TP enzymatic activity was not required for this effect of TP. Jurkat/TP cells showed weak phosphorylation of Bcl-2, and kinase inhibitors staurosporine and genistein attenuated not only MIA-induced Bcl-2 phosphorylation but also cytotoxicity of MIA in Jurkat/CV, but not in Jurkat/TP. MIAs diminished expression of FasL in Jurkat/TP but not in Jurkat/CV, and neutralization of FasL by anti-FasL antibody considerably attenuated the cytotoxic effect of the MIAs in Jurkat/CV, but the effect of the antibody was marginal in Jurkat/TP cells. Our study provides further evidence that TP functions in conferring resistance on cancer cells to the stress induced by MIAs. In addition, we show that TP-induced inhibition of Bcl-2 phosphorylation and suppression of FasL may contribute to the protective function of TP in cancer cells.
我们研究了胸苷磷酸化酶(TP)赋予癌细胞对微管干扰剂(MIA)诱导的凋亡的抗性的能力。用TP cDNA稳定转染Jurkat细胞(Jurkat/TP),并检测其对MIA的敏感性。与mock转染的Jurkat/CV细胞相比,Jurkat/TP细胞对诺考达唑、长春新碱、长春碱、紫杉醇和2-甲氧基雌二醇诱导的凋亡更具抗性。TP的这种作用不需要TP酶活性。Jurkat/TP细胞显示Bcl-2的磷酸化较弱,激酶抑制剂星形孢菌素和染料木黄酮不仅减弱了MIA诱导的Jurkat/CV细胞中Bcl-2的磷酸化,还减弱了MIA的细胞毒性,但对Jurkat/TP细胞没有作用。MIA降低了Jurkat/TP细胞中FasL的表达,但对Jurkat/CV细胞没有影响,抗FasL抗体中和FasL可显著减弱MIA对Jurkat/CV细胞的细胞毒性作用,但该抗体对Jurkat/TP细胞的作用很小。我们的研究进一步证明TP在赋予癌细胞对MIA诱导的应激的抗性中发挥作用。此外,我们表明TP诱导的Bcl-2磷酸化抑制和FasL抑制可能有助于TP在癌细胞中的保护功能。